These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27465123)

  • 41. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antisolvent precipitation of lipid nanoparticles in microfluidic systems - A comparative study.
    Riewe J; Erfle P; Melzig S; Kwade A; Dietzel A; Bunjes H
    Int J Pharm; 2020 Apr; 579():119167. PubMed ID: 32087265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization.
    Nasr M; Nawaz S; Elhissi A
    Int J Pharm; 2012 Oct; 436(1-2):611-6. PubMed ID: 22842623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surface-active solid lipid nanoparticles as Pickering stabilizers for oil-in-water emulsions.
    Gupta R; Rousseau D
    Food Funct; 2012 Mar; 3(3):302-11. PubMed ID: 22237667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surface roughness and charge influence the uptake of nanoparticles: fluorescently labeled pickering-type versus surfactant-stabilized nanoparticles.
    Schrade A; Mailänder V; Ritz S; Landfester K; Ziener U
    Macromol Biosci; 2012 Nov; 12(11):1459-71. PubMed ID: 22976936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Passive and active target delivery of drugs to ischemic myocardium.
    Galagudza MM; Korolev DV; Sonin DL; Alexandrov IV; Minasian SM; Postnov VN; Kirpicheva EB; Papayan GV; Uskov IS
    Bull Exp Biol Med; 2011 Nov; 152(1):105-7. PubMed ID: 22803053
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein.
    Yoo JH; Shanmugam S; Thapa P; Lee ES; Balakrishnan P; Baskaran R; Yoon SK; Choi HG; Yong CS; Yoo BK; Han K
    Arch Pharm Res; 2010 Mar; 33(3):417-26. PubMed ID: 20361307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
    Dening TJ; Rao S; Thomas N; Prestidge CA
    Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery.
    Müller RH; Harden D; Keck CM
    Drug Dev Ind Pharm; 2012 Apr; 38(4):420-30. PubMed ID: 22088169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Switchable pickering emulsions stabilized by silica nanoparticles hydrophobized in situ with a switchable surfactant.
    Jiang J; Zhu Y; Cui Z; Binks BP
    Angew Chem Int Ed Engl; 2013 Nov; 52(47):12373-6. PubMed ID: 24123666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular uptake pathway and drug release characteristics of drug-encapsulated glycol chitosan nanoparticles in live cells.
    Park S; Lee SJ; Chung H; Her S; Choi Y; Kim K; Choi K; Kwon IC
    Microsc Res Tech; 2010 Sep; 73(9):857-65. PubMed ID: 20232459
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracellular trafficking of solid lipid nanoparticles and their distribution between cells through tunneling nanotubes.
    Kristl J; Plajnšek KT; Kreft ME; Janković B; Kocbek P
    Eur J Pharm Sci; 2013 Sep; 50(1):139-48. PubMed ID: 23628779
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymer-Coated Hollow Mesoporous Silica Nanoparticles for Triple-Responsive Drug Delivery.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Luo Z; Zhao Y
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18179-87. PubMed ID: 26221866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural oil nanoemulsions as cores for layer-by-layer encapsulation.
    Adamczak M; Para G; Simon C; Warszyński P
    J Microencapsul; 2013; 30(5):479-89. PubMed ID: 23489013
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced delivery of nano- and submicron particles using elongated microparticles.
    Raphael AP; Sisney JP; Liu DC; Prow TW
    Curr Drug Deliv; 2015; 12(1):78-85. PubMed ID: 25176162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of propylene glycol on aqueous silica dispersions and particle-stabilized emulsions.
    Binks BP; Fletcher PD; Thompson MA; Elliott RP
    Langmuir; 2013 May; 29(19):5723-33. PubMed ID: 23627647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FRET spectral unmixing: a ratiometric fluorescent nanoprobe for hypochlorite.
    Chen G; Song F; Wang J; Yang Z; Sun S; Fan J; Qiang X; Wang X; Dou B; Peng X
    Chem Commun (Camb); 2012 Mar; 48(24):2949-51. PubMed ID: 22237551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synergistic formation and stabilization of oil-in-water emulsions by a weakly interacting mixture of zwitterionic surfactant and silica nanoparticles.
    Worthen AJ; Foster LM; Dong J; Bollinger JA; Peterman AH; Pastora LE; Bryant SL; Truskett TM; Bielawski CW; Johnston KP
    Langmuir; 2014 Feb; 30(4):984-94. PubMed ID: 24409832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.